CD274 and cancer: The findings indicated that PD-1 rs2227981 and rs11568821 polymorphisms as well as PDL-1 rs4143815 variant significantly decreased the overall cancer risk, while PD-1 rs7421861 polymorphism significantly increased the risk of overall cancer.